Delivery Order SPE2DB24D9238-SPE2DB25FDQYE
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,812.70 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order covers the supply of EYLEA HD 8 mg/0.07 mL vials, a prescription pharmaceutical product, with an ultimate completion date of October 6, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on August 18, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order was issued without a set-aside designation and is set to be completed by September 9, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's facility...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for EYLEA HD 8 MG/0.07 ML vials with a ceiling value of $39,625.20. This firm fixed-price delivery order, awarded on September 3, 2025, represents a single supply requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,925.08 on July 29, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This award is funded by the Department of Defense through its Medical Supply Chain function and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,775.24 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, which is not designated as a set-aside award, is expected to be completed by October 9, 2025, with performance taking place at the awardee's Park Ridge location. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 for EYLEA HD 8 mg/0.07 ml vials on September 3, 2025. The contract, which carries no set-aside designation, calls for delivery by September 24, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain program. This delivery order represents a single purchase of a specialized pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $24,446 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, which carries no set-aside designation, is scheduled for completion by October 15, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,081.24 by the Defense Logistics Agency on August 11, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 2, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's existing...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQYEDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Eylea HD 8 mg/0.07 ml vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of August 27, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide. Eylea HD is a prescription ophthalmic medication used primarily to treat age-related macular degeneration and other retinal conditions within Department of Defense healthcare systems. This delivery order represents a routine pharmaceutical supply transaction within DMS Pharmaceutical Group's established role as a key supplier in the federal pharmaceutical supply chain. The company's consistent success in securing federal contracts with the DLA demonstrates its capability to fulfill critical medical supply requirements for military healthcare facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 8/6/25 |